VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,907 | -37.9% | 4,418 | -9.0% | 0.03% | -36.2% |
Q2 2023 | $78,732 | -19.7% | 4,857 | -85.2% | 0.05% | +6.8% |
Q1 2022 | $98,000 | -38.4% | 32,708 | -5.6% | 0.04% | -26.7% |
Q4 2021 | $159,000 | -27.7% | 34,653 | -0.9% | 0.06% | -38.1% |
Q3 2021 | $220,000 | 0.0% | 34,971 | -4.9% | 0.10% | +7.8% |
Q2 2021 | $220,000 | -22.3% | 36,791 | -17.8% | 0.09% | -25.0% |
Q1 2021 | $283,000 | +14.1% | 44,755 | +1.8% | 0.12% | +16.5% |
Q4 2020 | $248,000 | +0.4% | 43,966 | +3.4% | 0.10% | -20.8% |
Q3 2020 | $247,000 | -29.0% | 42,507 | -12.0% | 0.13% | -21.2% |
Q2 2020 | $348,000 | +64.2% | 48,320 | +6.9% | 0.16% | +89.7% |
Q1 2020 | $212,000 | -49.0% | 45,220 | -12.7% | 0.09% | +27.9% |
Q4 2019 | $416,000 | +88.2% | 51,823 | +61.2% | 0.07% | +51.1% |
Q3 2019 | $221,000 | -21.6% | 32,151 | -5.3% | 0.04% | -23.7% |
Q2 2019 | $282,000 | -1.7% | 33,941 | +17.6% | 0.06% | -90.3% |
Q1 2019 | $287,000 | +16.2% | 28,854 | -10.7% | 0.61% | +1354.8% |
Q4 2018 | $247,000 | -64.5% | 32,311 | -19.1% | 0.04% | -41.7% |
Q3 2018 | $696,000 | +5.8% | 39,960 | -42.3% | 0.07% | -87.6% |
Q2 2018 | $658,000 | – | 69,305 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |